Skip to menu Skip to content Skip to footer

Pharmaceutical Development of Innovative "Trojan Horse" Anti-Cancer Agents that Inhibit Desmoplasia by Reprogramming Signalling (NHMRC Ideas Grant administered by Griffith University) (2023-2025)

Experts

Professor Paul Bernhardt

Professor
School of Chemistry and Molecular Biosciences
Faculty of Science
Paul Bernhardt
Paul Bernhardt